Brief: SynAct Pharma Q1 Pretax Loss Widens To SEK 4.7 Mln
24/04/2019 12:06
April 24 (Reuters) - SynAct Pharma AB SYNACT.TE :
* Q1 PRETAX LOSS SEK 4.7 MILLION VERSUS LOSS SEK 3.5 MILLION
YEAR
AGO
Source text for Eikon: ID:nNDL27Bqr1
Further company coverage: SYNACT.TE
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on SynAct Pharma AB
See all newsSweden's SynAct Pharma Q3 net loss narrows as expenses fall
Brief: SynAct Pharma Q3 Net Income SEK -32.177 Million
Brief: SynAct Pharma Signs First Commercial Partnership For Resomelagon
Brief: WHO Names Resomelagon Among Key Dengue Drug Candidates
Brief: SynAct Pharma Says Advance Analysis Supports Phase 3 Development